We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates. It garnered $16.7 billion in revenue and adjusted earnings of $1.57 per share ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $147.00. The company’s shares closed ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Merck (NYSE:MRK) is another undervalued name among pharmaceutical stocks. In the last 12 months, MRK stock has remained ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most promising low-cost stocks. The September Consumer Price Index data showed that consumer ...

Therefore, with multiple growth catalysts, AZN stock is poised for a meaningful rally. Merck (NYSE:MRK) is another blue-chip among pharmaceutical stocks to buy at a valuation gap. MRK stock has ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.